Labomar develops and manufactures nutraceuticals and health supplements, focusing on innovation and safety in its products. The company is self-described as a Certified B Corporation, reflecting its commitment to social and environmental performance.

Labomar

IPhone / Mobile Compatible

Viewport Meta

Domain Not Resolving

Apple Mobile Web Clips Icon

Euro

Google Font API

HSTS

Google Maps

WordPress

reCAPTCHA

Owner

Kivanç Algan

Supply Chain Manager

Giacomo Mazzon

Corporate & Legal Affairs Manager

Laura Dan

Engineering Project Manager

Luca Volpato

Product Manager

Renata Pintarić

General Manager

Luciano Marton

Walter Bertin

Founder & CEO

Europe, Middle East, and Africa (EMEA) Manufacturing Companies (Top 10K)

Private Veneto Companies (Top 10K)

Europe Manufacturing Companies (Top 10K)

Veneto Companies (Top 10K)

Founded in 1998, Labomar specialises in the manufacture of dietary supplements, diet foods, health products and medical devices, using the innovative patents developed by its R&D division Labomar Research.
Labomar products are a guarantee of safety for Customers and End-users, in compliance with the principles of Good Manufacturing Practice and Quality.

Fondo Italiano d'Investimento

Venture Round - LABOMAR

Istrana

Veneto

Italy

Europe

LABOMAR

Labomar obtains B CORP certification together with Importfab and Welcare

First Capital exits Labomar and cashes in EUR9 million

Labomar's revenues grow by double digits in the first half of the year

Labomar board assesses congruous value of LBM Next's takeover bid

Labomar, condition precedent for LBM takeover bid comes true

Saudi Arabia

Asia

India

United States

North America

HTML5

Google Compute Engine

Google Tag Manager

Office 365

Google Analytics

jQuery

Microsoft Outlook

Google Fonts

Wordpress

Bootstrap

Labomar S.p.A. researches, develops, manufactures, and sells food supplements, medical devices, cosmetics, and pharmaceutical products in Italy, France, Poland, Spain, North America, and internationally. It offers food supplements for various therapeutic areas, including immune systems, gastroenterology, cough and cold, neurology, oncology, eyesight wellness, sport, dermatology, inside beauty, cardiology, orthopedics, pediatrics, detoxing, and metabolic syndrome; and vitamins, minerals, and antioxidants. The company also provides medical devices for the use in gynaecology, cough and cold, gastroenterology, wound healing, metabolic syndrome, proctology, detoxing, and oral wound care therapeutic areas; and foods for special medical purposes, such as gastroenterology, endocrinology, and dysphagia. In addition, it offers cosmetics for inside beauty, skin cleanser, skincare, haircare, oral wound care, sun care, dermatology, acne rosacea, acne, atopic dertmatitis, and bruises therapeutic areas; and probiotic food supplements. Further, the company provides contract development and manufacturing services. Labomar S.p.A. offers its products in the form of tablets, capsules, liquids, powders, and semi solids. It has a commercial agreement with Bayer for the development and production of the references in various pharmaceutical flavors and forms. The company was founded in 1998 and is headquartered in Istrana, Italy.

Labomar S.p.A.

news_impact_assignment_basic

key_people

merger_acquisitions

network_dossier

public_peers

news_daily_refresh

news_processing_daily_refresh

news_impact_assignment_daily

news_processing_basic

legal

legal_dossier

bundesanzeiger

events_dossier

partnerships_market_presence_dossier

partnerships_market_presence

company_dossier

network

strategic_challenges

industry_trends

strategic_challenges_dossier

industry_trends_dossier

company_summary

events

network_mapping

transactions_dossier

swot_dossier

signals

financial_statements

crunchbase_trigger

crunchbase_profile

li_profile

financials_download_nd

private_financials

swot_analysis

financial_legal_advisories

company_structure

industry_analysis

financial_analysis

funding_rounds_analysis

regulatory_analysis

competition_analysis

news_impact_assignment_advanced

news_processing_advanced

news_advanced

purchaser_profile

network_onboarding

translate_crunchbase_fundingrounds

peers

customer_profile

news_basic

valuation

news impact assignment basic	general
public peers	general	Sep 27, 2024 5:09 PM	108a9fd2
news daily refresh	general
news processing daily refresh	general
news impact assignment daily	general
news processing basic	general
company summary	general
signals	general	Sep 27, 2024 5:09 PM	84acae38
crunchbase trigger	general	Oct 30, 2024 1:02 PM	85ae4455
crunchbase profile	general	Oct 30, 2024 4:52 PM	be038030
li profile	general
translate crunchbase fundingrounds	general	Nov 6, 2024 3:12 PM	6bb9861b
peers	general	Sep 27, 2024 5:09 PM	6f78420f
news basic	general	Sep 27, 2024 5:09 PM	3cdac887
bundesanzeiger	filings
financials download nd	financials
private financials	financials

LBM

COM:LABOMAR

Labomar

Last Close

10.00

23/08 12:12

Market Cap

183.92M

Beta: -

Volume Today

1.75K

Avg: -